Loading...

Shannon Matzinger

Title
InstitutionUniversity of California Davis
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Carroll TD, Jegaskanda S, Matzinger S, Fritts L, McChesney MB, Kent SJ, Fairman J, Miller CJ. A lipid/DNA adjuvant-inactivated influenza virus vaccine protects rhesus macaques from uncontrolled virus replication after heterosubtypic influenza A virus challenge. J Infect Dis. 2018 Apr 26. PMID: 29701840.
      View in: PubMed
    2. Tian D, Sooryanarain H, Matzinger S, Gauger PC, Karuppannan AK, Elankumaran S, Opriessnig T, Meng XJ. Protective efficacy of a virus-vectored multi-component vaccine against porcine reproductive and respiratory syndrome virus, porcine circovirus type 2 and swine influenza virus. J Gen Virol. 2017 Dec; 98(12):3026-3036. PMID: 29091579.
      View in: PubMed
    3. Opriessnig T, Gerber PF, Matzinger S, Meng XJ, Halbur PG. Markedly different immune responses and virus kinetics in littermates infected with porcine circovirus type 2 or porcine parvovirus type 1. Vet Immunol Immunopathol. 2017 Sep; 191:51-59. PMID: 28895867.
      View in: PubMed
    4. Tian D, Cao D, Lynn Heffron C, Yugo DM, Rogers AJ, Overend C, Matzinger S, Subramaniam S, Opriessnig T, LeRoith T, Meng XJ. Enhancing heterologous protection in pigs vaccinated with chimeric porcine reproductive and respiratory syndrome virus containing the full-length sequences of shuffled structural genes of multiple heterologous strains. Vaccine. 2017 04 25; 35(18):2427-2434. PMID: 28343773.
      View in: PubMed
    5. Opriessnig T, Xiao CT, Halbur PG, Gerber PF, Matzinger S, Meng XJ. A commercial porcine circovirus (PCV) type 2a-based vaccine reduces PCV2d viremia and shedding and prevents PCV2d transmission to naïve pigs under experimental conditions. Vaccine. 2017 01 05; 35(2):248-254. PMID: 27919634.
      View in: PubMed
    6. Subramaniam S, Cao D, Tian D, Cao QM, Overend C, Yugo DM, Matzinger S, Rogers AJ, Heffron CL, Catanzaro N, Kenney SP, Opriessnig T, Huang YW, Labarque G, Wu SQ, Meng XJ. Efficient priming of CD4?T cells by Langerin-expressing dendritic cells targeted with porcine epidemic diarrhea virus spike protein domains in pigs. Virus Res. 2017 01 02; 227:212-219. PMID: 27784629.
      View in: PubMed
    7. Matzinger S, Opriessnig T, Xiao CT, Catanzaro N, Beach NM, Slade DE, Nitzel GP, Meng XJ. A chimeric virus created by DNA shuffling of the capsid genes of different subtypes of porcine circovirus type 2 (PCV2) in the backbone of the non-pathogenic PCV1 induces protective immunity against the predominant PCV2b and the emerging PCV2d in pigs. Virology. 2016 11; 498:82-93. PMID: 27564544.
      View in: PubMed
    8. Piñeyro PE, Kenney SP, Giménez-Lirola LG, Heffron CL, Matzinger S, Opriessnig T, Meng XJ. Expression of antigenic epitopes of porcine reproductive and respiratory syndrome virus (PRRSV) in a modified live-attenuated porcine circovirus type 2 (PCV2) vaccine virus (PCV1-2a) as a potential bivalent vaccine against both PCV2 and PRRSV. Virus Res. 2015 Dec 02; 210:154-64. PMID: 26239318.
      View in: PubMed
    9. Subramaniam S, Piñeyro P, Tian D, Overend C, Yugo DM, Matzinger S, Rogers AJ, Haac ME, Cao Q, Heffron CL, Catanzaro N, Kenney SP, Huang YW, Opriessnig T, Meng XJ. In vivo targeting of porcine reproductive and respiratory syndrome virus antigen through porcine DC-SIGN to dendritic cells elicits antigen-specific CD4T cell immunity in pigs. Vaccine. 2014 Nov 28; 32(50):6768-75. PMID: 25446829.
      View in: PubMed
    10. Opriessnig T, Gerber PF, Xiao CT, Halbur PG, Matzinger S, Meng XJ. Commercial PCV2a-based vaccines are effective in protecting naturally PCV2b-infected finisher pigs against experimental challenge with a 2012 mutant PCV2. Vaccine. 2014 Jul 23; 32(34):4342-8. PMID: 24929119.
      View in: PubMed
    11. Carroll TD, Matzinger S, Barry PA, McChesney MB, Fairman J, Miller CJ. Efficacy of influenza vaccination of elderly rhesus macaques is dramatically improved by addition of a cationic lipid/DNA adjuvant. J Infect Dis. 2014 Jan 01; 209(1):24-33. PMID: 24141979; PMCID: PMC3864389.
    12. Matzinger S, Carroll TD, Dutra JC, Ma ZM, Miller CJ. Myxovirus resistance gene A (MxA) expression suppresses influenza A virus replication in alpha interferon-treated primate cells. J Virol. 2013 Jan; 87(2):1150-8. PMID: 23152507; PMCID: PMC3554078.
    13. Matzinger S, Carroll TD, Fritts L, McChesney MB, Miller CJ. Exogenous IFN-alpha administration reduces influenza A virus replication in the lower respiratory tract of rhesus macaques. PLoS One. 2011; 6(12):e29255. PMID: 22220209; PMCID: PMC3248419.
    14. Carroll TD, Matzinger S, Fritts L, McChesney MB, Miller CJ. Memory B cells and CD8? lymphocytes do not control seasonal influenza A virus replication after homologous re-challenge of rhesus macaques. PLoS One. 2011; 6(6):e21756. PMID: 21747924; PMCID: PMC3126839.
    15. Carroll TD, Matzinger S, Barro M, Fritts L, McChesney MB, Miller CJ, Johnston RE. Alphavirus replicon-based adjuvants enhance the immunogenicity and effectiveness of Fluzone ® in rhesus macaques. Vaccine. 2011 Jan 29; 29(5):931-40. PMID: 21111777; PMCID: PMC3026063.
    16. Lay M, Callejo B, Chang S, Hong DK, Lewis DB, Carroll TD, Matzinger S, Fritts L, Miller CJ, Warner JF, Liang L, Fairman J. Cationic lipid/DNA complexes (JVRS-100) combined with influenza vaccine (Fluzone) increases antibody response, cellular immunity, and antigenically drifted protection. Vaccine. 2009 Jun 12; 27(29):3811-20. PMID: 19406188; PMCID: PMC2690618.
    17. Carroll TD, Matzinger S, Genescà M, Fritts L, Colòn R, McChesney MB, Miller CJ. Interferon-induced expression of MxA in the respiratory tract of rhesus macaques is suppressed by influenza virus replication. J Immunol. 2008 Feb 15; 180(4):2385-95. PMID: 18250448.
      View in: PubMed
    Shannon's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _